Selinexor in Patients With Advanced Thymic Epithelial Tumor Progressing After Primary Chemotherapy
Clinical trial NCT03193437 · TERMINATED
Trial details
- NCT number
- NCT03193437
- Sponsor
- Georgetown University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-03
- Primary completion
- 2020-07-27
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.